Table 1.
Baseline characteristics of patients with and without major adverse cardiovascular events.
| Baseline characteristics |
No event (n = 182) |
Yes event (n = 125) |
Total (n = 307) |
|
|---|---|---|---|---|
| Age, mean ± SD, years |
61.9 ±10.1 | 65.7 ±10.7 | 63.5 ± 10.5 | |
| Men, n (%) | 154 (84.6) | 100 (80.0) | 254 (82.7) | |
| White race, n (%) | 153 (84.1) | 97 (77.6) | 250 (81.4) | |
| BMI, mean ± SD kg/m2 |
28.8 ± 4.7 | 29.0 ± 4.8 | 28.9 ± 4.8 | |
| Smoking, n (%) | ||||
| Current | 16 (8.8) | 27 (21.6) | 43 (14.0) | |
| Past | 99 (54.4) | 69 (55.2) | 168 (54.7) | |
| Never | 67 (36.8) | 29 (23.2) | 96 (31.3) | |
| Prior MI, n (%) | 83 (45.6) | 53 (42.4) | 136 (44.3) | |
| Prior PTCA, n (%) | 106 (58.2) | 86 (68.8) | 192 (62.5) | |
| Prior CABG, n (%) | 73 (40.1) | 61 (48.8) | 134 (43.7) | |
| Hx of DM, n (%) | 47 (25.8) | 41 (32.8) | 88 (28.7) | |
| Hx of HTN, n (%) | 143 (78.6) | 103 (82.4) | 246 (80.1) | |
| Hx of hyperlipidemia, n (%) |
171 (94.0) | 118 (94.4) | 289 (94.1) | |
| Hx of depression, n (%) |
26 (14.3) | 17 (13.6) | 43 (14.0) | |
| NYHA functional class, n (%) | ||||
| I | 175 (96.2) | 107 (85.6) | 282 (91.9) | |
| II | 6 (3.3) | 14 (11.2) | 20 (6.5) | |
| III | 1 (0.6) | 4 (3.2) | 5 (1.6) | |
| ASA, n (%) | 175 (97.2) | 117 (93.6) | 292 (95.7) | |
| Other antiplatelet agent, n (%) |
68 (37.6) | 64 (51.2) | 132 (43.1) | |
| ACEI, n (%) | 115 (63.5) | 81 (64.8) | 196 (64.1) | |
| Angiotensin II, n (%) | 22 (12.2) | 18 (14.4) | 40 (13.1) | |
| β-Blockers, n (%) | 151 (83.4) | 105 (84) | 256 (83.7) | |
| Calcium channel blockers, n (%) |
41 (22.7) | 29 (23.4) | 70 (23.0) | |
| Statin, n (%) | 167 (92.3) | 113 (91.9) | 280 (92.1) | |
| Other lipid-lowering agent, n (%) |
51 (29.0) | 29 (24.0) | 80 (26.9) | |
| Baseline SBP, mean ± SD mm Hg |
126 ± 19 | 128 ± 18 | 127 ± 18 | |
| Baseline DBP, mean ± SD mm Hg |
73 ± 12 | 73 ± 11 | 73 ± 11 | |
| Baseline HR, mean ± SD beats/min |
67 ± 10 | 69 ± 11 | 68 ± 11 | |
| Baseline LVEF, mean ± SD |
58 ± 10 | 55 ± 11 | 57 ± 10 | |
ACEI: acetycholinesterase inhibitor; ASA: aspirin; BMI: body mass index; CABG: coronary artery bypass graft; DBP: diastolic blood pressure; DM: diabetes mellitus; HR: heart rate; HTN: hypertension; LVEF: left ventricular ejection fraction; MI: myocardial infarction; NYHA: New York Heart Association; PTCA: percutaneous transluminal coronary angioplasty; SBP: systolic blood pressure; SD: standard deviation. Hx: history.